Joint Clinical Trials Office

You are here

Pancreatic Cancer Early Detection Using a Urine Test for Mutated K-ras DNA

Clinical Trial Details

This clinical trial is for men and women diagnosed with metastatic pancreatic cancer as well as healthy individuals. The purpose of this research study is to develop a safe method for finding pancreatic cancer using a new technology of finding and detecting pancreatic cancer DNA markers in adult urine. In order to continue to improve the way pancreatic cancer is found in patients, the researchers must be able to obtain urine samples from patients who may or may not have pancreatic cancer and test their urine for DNA fragments that contains pancreatic DNA markers. Eligible patients will have urine and blood collected for correlative reference. 

Key Eligibility: 

 - Men and women age 18 or older 
- Patient cohort: known diagnosis of pancreatic cancer 
- Control cohort: no known pancreatic cancer 
- Detailed eligibility reviewed when you contact the study team 

Study contact by location

Upper East Side - Manhattan

Contact(s)

Sabrina Machado, RN
646-962-3378
sam4006@med.cornell.edu

Primary Investigator(s)

Protocol ID(s)

Weill Cornell Medicine IRB #:

1502015918

Status

Open to Enrollment

Age Group

Adult

Sponsor